Harnessing Genome Scale Metabolic Modeling for the discovery of novel drug-targets in neurodegenerative disease.
Utilization of genome scale metabolic modeling for simulating neurodegenerative conditions, the discovery of novel drug-targets and their verification by electrophysiological recordings (EEG, Multi-Electrode-Array ).
SYSBIO 2014 – System biology workshop, Austria.
7th FISEB (Ilanit) congress, 2014, Israel
Tel-Aviv Nano-center conference, 2013, Israel.
21th Israel Society for Neuroscience conference (ISFN), 2012, Israel.
TAU center for Nanoscience and Nanotechnology Fellowship.
Research Categories: Computational neuroscience, Molecular Neuroscience